BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 1705190)

  • 21. A model for human calcium pyrophosphate crystal deposition disease: crystallization kinetics in a gelatin matrix.
    Mandel NS; Mandel GS
    Scan Electron Microsc; 1984; (Pt 4):1779-92. PubMed ID: 6098005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumoral calcium pyrophosphate dihydrate deposition disease: cytopathologic findings on fine-needle aspiration.
    Allen EA; Ali SZ; Erozan YS
    Diagn Cytopathol; 1996 Nov; 15(4):349-51. PubMed ID: 8982595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic widespread calcium pyrophosphate dihydrate crystal deposition disease in a young patient.
    Hayashi M; Matsunaga T; Tanikawa H
    Skeletal Radiol; 2002 Apr; 31(4):246-50. PubMed ID: 11904695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic release of microspheroids containing hydroxyapatite crystals from synovium and of calcium pyrophosphate dihydrate crystals from cartilage.
    Halverson PB; Cheung HS; McCarty DJ
    Ann Rheum Dis; 1982 Oct; 41(5):527-31. PubMed ID: 6289761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy.
    Martínez Sanchis A; Pascual E
    Ann Rheum Dis; 2005 Dec; 64(12):1769-72. PubMed ID: 15941838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium pyrophosphate dihydrate crystal deposition disease: a review of the literature and a light and electron microscopic study of a case of the temporomandibular joint with numerous intracellular crystals in the chondrocytes.
    Dijkgraaf LC; Liem RS; de Bont LG; Boering G
    Osteoarthritis Cartilage; 1995 Mar; 3(1):35-45. PubMed ID: 7719954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New knowledge on the calcium pyrophosphate dihydrate (CPPD) crystal deposition disease in the cervical ligamentum flavum].
    Kawano N; Matsuno T; Miyazawa S; Uchiyama H; Ohtaka H; Mii K; Tachibana S
    No Shinkei Geka; 1987 Feb; 15(2):181-90. PubMed ID: 3031524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Calcium pyrophosphate dihydrate crystal induced arthropathy].
    Announ N; Guerne PA
    Rev Med Suisse; 2007 Mar; 3(103):740-2, 744, 746. PubMed ID: 17458152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on identification of a calcium pyrophosphate dihydrate crystal using electron diffraction technique].
    Watanabe W
    Nihon Seikeigeka Gakkai Zasshi; 1991 Sep; 65(9):745-56. PubMed ID: 1960475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical aspects of calcium pyrophosphate dihydrate crystal deposition.
    Doherty M; Dieppe P
    Rheum Dis Clin North Am; 1988 Aug; 14(2):395-414. PubMed ID: 2845493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium pyrophosphate crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP; Adams ME; Nyburg SC; Omar SA
    J Rheumatol; 1980; 7(5):609-16. PubMed ID: 6255159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of polymorphonuclear leukocytes with calcium pyrophosphate dihydrate crystals deposited in chondrocalcinosis cartilage.
    Ishikawa H; Ueba Y; Isobe T; Hirohata K
    Rheumatol Int; 1987; 7(5):217-21. PubMed ID: 2827293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of chondrocyte production of extracellular inorganic pyrophosphate.
    Costello JC; Ryan LM
    Curr Opin Rheumatol; 2004 May; 16(3):268-72. PubMed ID: 15103256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of scanning and transmission electron microscopy, x-ray energy spectroscopy, and x-ray diffraction to calcium pyrophosphate crystal formation in vitro.
    Omar SA; Cheng PT; Nyburg SC; Pritzker KP
    Scan Electron Microsc; 1979; (2):745-9. PubMed ID: 230578
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibitory effect of low density lipoprotein on the inflammation-inducing activity of calcium pyrophosphate dihydrate crystals.
    Kumagai Y; Watanabe W; Kobayashi A; Sato K; Onuma S; Sakamoto H
    J Rheumatol; 2001 Dec; 28(12):2674-80. PubMed ID: 11764217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of joint motion on experimental calcium pyrophosphate dihydrate crystal induced arthritis.
    Fam AG; Schumacher HR; Clayburne G; Villanueva T; Baker D; Jimenez SA
    J Rheumatol; 1990 May; 17(5):644-55. PubMed ID: 2162961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of primary articular chondrocalcinosis.
    Zitnan D; Sitaj S
    Czech Med; 1979; 2(3):89-103. PubMed ID: 535502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cartilage of the head of the femoral in articular chondrocalcinosis (author's transl)].
    Vignon E; Arlot M; Meunier P; Vignon G
    Nouv Presse Med; 1977 Nov; 6(37):3397-400. PubMed ID: 600711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An ultrastructural study of articular chondrocalcinosis in cases of knee osteoarthritis.
    Boivin G; Lagier R
    Virchows Arch A Pathol Anat Histopathol; 1983; 400(1):13-29. PubMed ID: 6407192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint.
    Ryu K; Iriuchishima T; Oshida M; Kato Y; Saito A; Imada M; Aizawa S; Tokuhashi Y; Ryu J
    Osteoarthritis Cartilage; 2014 Jul; 22(7):975-9. PubMed ID: 24814686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.